Shandong Wohua Pharmaceutical Co., Ltd.(002107.SZ)
Profile
Registered Capital:
163.98(RMB MLN)
Employees:
711
Email:
lulu6961@sina.com

WebSite:
http://www.wohua.cn
Tel:
0536-8553373
Fax:
0536-8553373
Introduction from Google Finance
Shandong Wohua Pharmaceutical Co., Ltd. is principally engaged in the research, development, production and sale of Chinese traditional patent medicines for the treatment of cardiovascular and cerebrovascular disease. The Company offers tablets, hard capsules, granules, pills, powders, oral solutions, mixtures, alcoholature, soft extracts, syrup, dripping pills and extracorporeal diagnostic reagents, among others. The Company's major products are Xinkeshu tablets and capsules for the treatment of coronary heart disease; Naoxueshu Oral Liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza. The Company distributes its products throughout China, and eastern China is the major market.
Reports
News      more..
Revenue Breakdown (million RMB)
Industry2011H120102010H1200920082007
The pharmaceutical industry68.83**********
Pharmaceutical business--**********
Total--**********
Products2011H120102010H1200920082007
Of xinkeshu tablets************
Cerebral blood Shu oral liquid************
Generic medicine************
Total************
Area2011H120102010H1200920082007
East China36.99**********
North China and Northeast China13.58**********
South China10.56**********
Southwest0.46**********
Other areas7.23**********
Total68.83**********
Introduction from Company WebSite

Shandong Wohua Pharmaceutical Co., Ltd. is principally engaged in the research, development, production and sale of Chinese traditional patent medicines for the treatment of cardiovascular and cerebrovascular disease. The Company offers tablets, hard capsules, granules, pills, powders, oral solutions, mixtures, alcoholature, soft extracts, syrup, dripping pills and extracorporeal diagnostic reagents, among others. The Company's major products are Xinkeshu tablets and capsules for the treatment of coronary heart disease; Naoxueshu Oral Liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza. The Company distributes its products throughout China, and eastern China is the major market.

2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1
在线客服系统